Skip to main content

Track 1

The Medical Oncology/Hematology Fellowship Program is our dual certification (both hematology and medical oncology) clinical training program. Each year, there are five medical oncology/hematology positions offered. This is a three-year comprehensive clinical training program with many opportunities in clinical, translational and basic science research. Fellows will have the opportunity to work with our clinical research program and enroll patients in clinical trials. They will also work closely with a research mentor to develop their own research interests and projects.

The Monter Cancer Center, the principal site for the clinical fellowship training, is a major component of the Northwell Health Cancer Institute with over 200 affiliated physicians and research scientists. Our medical oncology/hematology physicians are organized in disease teams specializing in various solid and liquid tumors and benign hematology. Our faculty works closely with other colleagues in the Cancer Institute, including those from surgical oncology, radiation medicine, pathology and radiology, as well as the Cold Spring Harbor Laboratory (CSHL). They participate in over 100 clinical trials to provide the best and most advanced care for their patients. Research in our institution includes laboratory-based study, translational investigation, and the largest selection of advanced clinical trials on Long Island. Our research efforts are enhanced by our collaboration with the Feinstein Institute for Medical Research and the Cold Spring Harbor Laboratory.

Training outline

The Medical Oncology/Hematology Fellowship Program will provide extensive experience through a variety of settings, including inpatient rotations, outpatient rotations, research rotations and the fellow’s continuity clinic.

Inpatient rotations include:

  • North Shore University Hospital Hematology Consult Service
  • Long Island Jewish Medical Center Hematology Consult Service
  • North Shore University Hospital Oncology Consult Service
  • Long Island Jewish Medical Center Oncology Consult Service
  • Bone Marrow Transplant Service
  • 7 Monti Leukemia and Lymphoma Service

During the inpatient rotations, the fellow will develop into the role of the consultant and improve communication skills with patients, families, other physicians and healthcare providers. The inpatient rotation allows the fellow to go through the process of differential to confirmed diagnoses, as well as the management of acute complications due to patients’ underlying malignancies and their treatments. The fellow serves as the leader of the team. As a leader, the fellow is expected to assist in the teaching of medical students and residents on the rotation. Informal educational activities during the rotations will focus on continuous updating and monitoring of fellows’ knowledge base while emphasizing the philosophy of lifelong learning.

Outpatient rotations include:

  • Radiation Medicine
  • Hematopathology
  • CLL Program
  • Blood Banking
  • Treatment Room Monter Cancer Center
  • Assigned Disease Site Specific Ambulatory Rotations at Monter Cancer Center

Inpatient consult service rotations decrease from the first year to the third year for all clinical trainees, while outpatient experiences increase over the course of the three years. In each rotation, fellows participate in both initial consultations and longitudinal follow-up visits.

Continuity clinic

All fellows participate in the fellows continuity clinic weekly. Cases are assigned beginning the first year of training. These patients will be followed longitudinally for the duration of the fellowship under the supervision of an attending hematologist/oncologist. Fellows are responsible for all aspects of the patient’s care, including diagnosis, evaluation, ordering tests, treatments, patient follow-up and communication. First year fellows have one half day of continuity clinic each week. This increases in frequency to up to three half day sessions of continuity clinic by the third year of training. ACGME requires participation in continuity clinic for all trainees throughout the three years.

Track 2

Translational Research Training Program

In conjunction with the Cold Spring Harbor Laboratory (CSHL) – a National Cancer Institute designated Cancer Center, the Division of Medical Oncology has a new translational research track. This track includes 14 months of clinical training, followed by two years of post-doctoral basic or translational research at CSHL. After successful completion of the translational research track, the fellow will be eligible to take the medical oncology examination by the American Board of Internal Medicine.

CSHL has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. The CSHL Cancer Center is a basic research facility committed to exploring the fundamental biology of human cancer. The research covers a broad range of cancer types, including breast, prostate, leukemia, glioma, pancreatic, sarcoma, lung and melanoma. Three scientific programs provide focus in Gene Regulation & Cell Proliferation, Signal Transduction, and Cancer Genetics. The Cancer Center currently has approximately 37 faculty members. Read more about the CSHL Cancer Center research and faculty. Read more about this fellowship and the CSHL Cancer Center research and faculty.

Program candidates

Promising candidates must have an MD or MD/PhD and have completed an ACGME-accredited residency in Internal Medicine with a clear track record of academic accomplishments and/or research training. This fellowship targets candidates with a desire for a clinician-scientist career in medical oncology.

Training outline

The Translational Research Training Program will provide extensive basic science and translational research experience. Fellows will complete clinical requirements through a variety of settings, including inpatient rotations, outpatient rotations and the fellow’s continuity clinic. The clinical training rotations will be the same as our clinical program. The amount of rotations, however, will be decreased for the translational fellow due to single board eligibility requirements. These will be completed during the first year of training.

Inpatient rotations include:

  • North Shore University Hospital Hematology Consult Service
  • Long Island Jewish Medical Center Hematology Consult Service
  • North Shore University Hospital Oncology Consult Service
  • Long Island Jewish Medical Center Oncology Consult Service
  • Bone Marrow Transplant Service
  • 7 Monti Leukemia and Lymphoma Service

During the inpatient rotations, the fellow will develop into the role of the consultant and improve communication skills with patients, families, other physicians and healthcare providers. The inpatient rotation allows the fellow to go through the process of differential to confirmed diagnoses, as well as the management of acute complications due to patients’ underlying malignancies and their treatments. The fellow serves as a leader of the team. As a leader, the fellow is expected to assist in the teaching of medical students and residents on the rotation. The fellow will improve scholarship skills in critically evaluating medical literature and emphasize the philosophy of lifelong learning.

Outpatient rotations include:

  • Radiation Medicine
  • Hematopathology
  • CLL Program
  • Blood Banking
  • Treatment Room Monter Cancer Center
  • Assigned Disease Site Specific Ambulatory Rotations at Monter Cancer Center

Continuity clinic

All fellows participate in the continuity clinic weekly. Cases are assigned beginning the first year of training. These patients will be followed longitudinally for the duration of the fellowship under the supervision of an attending hematologist/ oncologist. Fellows are responsible for all aspects of the patient’s care, including diagnosis, evaluation, ordering tests, treatments, patient follow-up and communication.

Research

Each translational research program participant, whose goal is to pursue a career as a research scientist, has a minimum two-year period in the laboratory after completion of the clinical fellowship training. The clinical training opportunities are the same as our clinical program but will be decreased due to single board eligibility requirements. These will be completed during the first year of training. During the remaining two years, mentors from Cold Spring Harbor
Laboratory, will supervise the research training, implementation, and completion of all basic translational research projects. There will be the additional opportunity to continue to work as well with a clinical translational mentor from Northwell depending on the focus of the research program that is developed. All research fellows will continue to expand their knowledge by attending seminars and lectures at Cold Spring Harbor Laboratories. Trainees will become skilled in research ethics, biostatistics, and research methodology. Due to ACGME requirements, fellows in the translational track are required to continue to participate in a weekly continuity half day clinic throughout the three years of training to fulfill ACGME requirements.

Fellows Core Conference

All fellows, regardless of their track, participate in the Fellows Core Conference. The Fellowship Program has two core conferences each week. During these conferences, lectures are given by Northwell’s highly regarded faculty to review important topics such as:

  • Pharmacology of chemotherapeutic agents
  • Disease specific reviews
  • Cancer biology
  • Epigenetics
  • Immunotherapy
  • Genetics of cancer
  • Palliative care
  • Cancer research
  • Clinical trials

Journal Club

Fellows review and analyze current cancer related articles from peer reviewed journals in order to critically evaluate current published research in the future.

Oncology Grand Rounds

Fellows attend this weekly didactic lecture series given by world renowned faculty. Conferences include discussions on standard of care as well as current basic science and translational research efforts.

Hematology Grand Rounds

Fellows attend this weekly didactic lecture series on hematologic disorders. Conferences include discussions on standard of care as well as current basic science and translational research efforts. Each fellow is expected to present one Hematology Grand Rounds program during their second year of training.

Tumor Boards

Site specific multidisciplinary tumor boards include:

  • Breast
  • Thoracic
  • Genito-urinary
  • Gastrointestinal
  • Gynecologic oncology
  • Neuro-oncology
  • Head and neck cancer
  • Bone metastases
  • Hematologic malignancies

Fellows attend and present cases at the multidisciplinary tumor boards.​

Communication skills and professionalism

All first year fellows participate in an eight-week Communication in the Oncology Setting course that includes didactic lecture followed by role play learning.

National meetings

All fellows are encouraged to attend at least one national meeting per year that is supported by the program. All fellows are encouraged to present their research at national meetings.

Go to top